Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All

被引:45
作者
Bilcke, Joke [1 ]
Coenen, Samuel [2 ,3 ]
Beutels, Philippe [1 ,4 ]
机构
[1] Univ Antwerp, Fac Med & Hlth Sci, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst VAXINFECTIO,WHO Collabo, B-2020 Antwerp, Belgium
[2] Univ Antwerp, Fac Med & Hlth Sci, Ctr Gen Practice Primary & Interdisciplinary Care, B-2020 Antwerp, Belgium
[3] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol,WHO Collaborating Ctr, B-2020 Antwerp, Belgium
[4] Sch Publ Hlth & Community Med, Sydney, NSW, Australia
来源
PLOS ONE | 2014年 / 9卷 / 07期
基金
比利时弗兰德研究基金会;
关键词
HEALTHY-CHILDREN; VACCINATION; IMPACT;
D O I
10.1371/journal.pone.0102634
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This is one of the first studies to (1) describe the out-of-hospital burden of influenza-like-illness (ILI) and clinically diagnosed flu, also for patients not seeking professional medical care, (2) assess influential background characteristics, and (3) formally compare the burden of ILI in patients with and without a clinical diagnosis of flu. A general population sample with recent ILI experience was recruited during the 2011-2012 influenza season in Belgium. Half of the 2250 respondents sought professional medical care, reported more symptoms (especially more often fever), a longer duration of illness, more use of medication (especially antibiotics) and a higher direct medical cost than patients not seeking medical care. The disease and economic burden were similar for ambulatory ILI patients, irrespective of whether they received a clinical diagnosis of flu. On average, they experienced 5-6 symptoms over a 6-day period; required 1.6 physician visits and 86-91% took medication. An average episode amounted to is an element of 51-is an element of 53 in direct medical costs, 4 days of absence from work or school and the loss of 0.005 quality-adjusted life-years. Underlying illness led to greater costs and lower quality-of-life. The costs of ILI patients with clinically diagnosed flu tended to increase, while those of ILI patients without clinically diagnosed flu tended to decrease with age. Recently vaccinated persons experienced lower costs and a higher quality-of-life, but this was only the case for patients not seeking professional medical care. This information can be used directly to evaluate the implementation of cost-effective prevention and control measures for influenza. In particular to inform the evaluation of more widespread seasonal influenza vaccination, including in children, which is currently considered by many countries.
引用
收藏
页数:11
相关论文
共 25 条
  • [1] Burden of paediatric influenza in Western Europe: a systematic review
    Antonova, Evgeniya N.
    Rycroft, Catherine E.
    Ambrose, Christopher S.
    Heikkinen, Terho
    Principi, Nicola
    [J]. BMC PUBLIC HEALTH, 2012, 12
  • [2] Beutels P, 2013, SEASONAL INFLUENZA 2
  • [3] Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries
    Butler, C. C.
    Hood, K.
    Verheij, T.
    Little, P.
    Melbye, H.
    Nuttall, J.
    Statistician, M. J. Kelly
    Molstad, S.
    Godycki-Cwirko, M.
    Almirall, J.
    Torres, A.
    Gillespie, D.
    Rautakorpi, U.
    Coenen, S.
    Goossens, H.
    [J]. BRITISH MEDICAL JOURNAL, 2009, 338 : 1545
  • [4] Cleemput I., 2012, Health Technology Assessment (HTA)
  • [5] Clinical manifestations and socio-economic impact of influenza among healthy children in the community
    Esposito, Susanna
    Cantarutti, Luigi
    Molteni, Claudio Giuseppe
    Daleno, Cristina
    Scala, Alessia
    Tagliabue, Claudia
    Pelucchi, Claudio
    Giaquinto, Carlo
    Principi, Nicola
    [J]. JOURNAL OF INFECTION, 2011, 62 (05) : 379 - 387
  • [6] Self-medication with antimicrobial drugs in Europe
    Grigoryan, L
    Haaijer-Ruskamp, FM
    Burgerhof, JGM
    Mechtler, R
    Deschepper, R
    Tambic-Andrasevic, A
    Andrajati, R
    Monnet, DL
    Cunney, R
    Di Matteo, A
    Edelstein, H
    Valinteliene, R
    Alkerwi, A
    Scicluna, EA
    Grzesiowski, P
    Bara, AC
    Tesar, T
    Cizman, M
    Campos, J
    Lundborg, CS
    Birkin, J
    [J]. EMERGING INFECTIOUS DISEASES, 2006, 12 (03) : 452 - 459
  • [7] Impact of Influenza on Health-Related Quality of Life among Confirmed (H1N1) 2009 Patients
    Hollmann, Malen
    Garin, Olatz
    Galante, Mariana
    Ferrer, Montserrat
    Dominguez, Angela
    Alonso, Jordi
    [J]. PLOS ONE, 2013, 8 (03):
  • [8] Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies
    Jit, Mark
    Newall, Anthony T.
    Beutels, Philippe
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (04) : 834 - 840
  • [9] Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial
    Little, Paul
    Stuart, Beth
    Moore, Michael
    Coenen, Samuel
    Butler, Christopher C.
    Godycki-Cwirko, Maciek
    Mierzecki, Artur
    Chlabicz, Slawomir
    Torres, Antoni
    Almirall, Jordi
    Davies, Mel
    Schaberg, Tom
    Molstad, Sigvard
    Blasi, Francesco
    De Sutter, An
    Kersnik, Janko
    Hupkova, Helena
    Touboul, Pia
    Hood, Kerenza
    Mullee, Mark
    O'Reilly, Gilly
    Brugman, Curt
    Goossens, Herman
    Verheij, Theo
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (02) : 123 - 129
  • [10] The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews
    Michiels, Barbara
    Van Puyenbroeck, Karolien
    Verhoeven, Veronique
    Vermeire, Etienne
    Coenen, Samuel
    [J]. PLOS ONE, 2013, 8 (04):